Product is not available
The Qiagen digene HC2 High-Risk HPV DNA Test is an FDA-approved in vitro diagnostic assay that detects 13 high-risk human papillomavirus (HPV) types using advanced Hybrid Capture 2 (HC2) technology. This qualitative test uses nucleic acid hybridization with signal amplification and chemiluminescent detection to deliver standardized and clinically validated results. It is widely used for cervical cancer screening and is suitable for both low- and high-volume testing environments.
Note: The price mentioned above is for reference only. Do not consider it for purchase.
Key features
Detects 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)
Utilizes Hybrid Capture 2 technology for high clinical sensitivity
FDA-approved and extensively validated in clinical settings
Standardized, objective test results with low risk of false negatives
Chemiluminescent signal detection for high reliability
Suitable for automated or manual workflows
For use with cervical specimens collected using approved devices (e.g., digene Cervical Sampler, PreservCyt)
Disclaimer: UNLESS OTHERWISE INDICATED, THE CONTENT OF THIS WEBSITE IS THE PROPRIETARY PROPERTY OF ITS OWNERS. However, trademarks, service marks and/or logos (called "marks") herein associated with the products listed on this website are the property of their respective owners. If they appear with the listed products, it is only used for the purpose of identification of those products. We do not claim any association with the mark owners, unless otherwise so specified. MEANING OF LIST NUMBER: R – Refurbished, PO – Preowned, U – Used, T – Trading, M – Own Manufactured, AD - Authorized Dealer of Original Equipment Manufacturer.
